Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.

Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.

Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved in the development and progression of prostate cancer and the ultimate failure of androgen-deprivation therapy. To investigate the metabolism regulation effects on androgen-independent growth of prostate cancer,...

Full description

Bibliographic Details
Main Authors: Lei Yan, Zhaoquan Xing, Zhaoxin Guo, Zhiqing Fang, Wei Jiao, Xiaoyu Guo, Zhonghua Xu, Zhenghui Fang, Anders Holmberg, Sten Nilsson, Zhaoxu Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3567093?pdf=render

Internet

http://europepmc.org/articles/PMC3567093?pdf=render

Similar Items